BenevolentAI SA
AEX:BAI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
|
BR |
|
B
|
Beijing Cuiwei Tower Co Ltd
SSE:603123
|
CN |
|
Shreyans Industries Ltd
NSE:SHREYANIND
|
IN |
|
L E Lundbergforetagen AB (publ)
STO:LUND B
|
SE |
We don't have any information about BAI's insider trading.
BenevolentAI SA
Glance View
BenevolentAI SA is a holding company that engages in the research and development and sale of AI-enabled drugs. The firm through the combined capabilities of its AI platform, scientific ability and wet-lab facilities deliver new drug candidates with a higher probability of clinical success than those developed using traditional methods. The company has an array of scientifically validated discoveries. The Company, through its BenevolentAI Platform, offers in-house pipeline of over 20 disease programs, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies, such as AstraZeneca, as well as other research and charitable institutions.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
